Robyn J. Levy

3.1k total citations
37 papers, 1.6k citations indexed

About

Robyn J. Levy is a scholar working on Genetics, Immunology and Hematology. According to data from OpenAlex, Robyn J. Levy has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 13 papers in Immunology and 12 papers in Hematology. Recurrent topics in Robyn J. Levy's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (29 papers), Mast cells and histamine (9 papers) and Autoimmune Bullous Skin Diseases (9 papers). Robyn J. Levy is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (29 papers), Mast cells and histamine (9 papers) and Autoimmune Bullous Skin Diseases (9 papers). Robyn J. Levy collaborates with scholars based in United States, Romania and Israel. Robyn J. Levy's co-authors include H. Henry Li, Timothy Craig, Marco Cicardi, William E. Pullman, Patrick T. Horn, Marilyn Campion, Richard L. Wasserman, Dumitru Moldovan, Donald McNeil and Avner Reshef and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Robyn J. Levy

37 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robyn J. Levy United States	19	1.4k	580	521	466	461	37	1.6k
Andrea Zanichelli Italy	30	2.8k 2.0×	1.3k 2.3×	735 1.4×	816 1.8×	693 1.5×	111	3.1k
María L Santaella Puerto Rico	10	411 0.3×	179 0.3×	157 0.3×	180 0.4×	141 0.3×	20	657
L Steinmann United States	16	722 0.5×	183 0.3×	714 1.4×	147 0.3×	12 0.0×	21	1.2k
Alison May United Kingdom	17	457 0.3×	314 0.5×	512 1.0×	52 0.1×	220 0.5×	44	1.1k
A. O’Meara Ireland	13	139 0.1×	122 0.2×	207 0.4×	61 0.1×	46 0.1×	20	872
Anna Serra Italy	21	460 0.3×	113 0.2×	658 1.3×	46 0.1×	11 0.0×	64	1.2k
Carmine D’Urzo Italy	8	151 0.1×	100 0.2×	164 0.3×	58 0.1×	19 0.0×	15	505
Jean‐Michel Pignon France	9	282 0.2×	224 0.4×	417 0.8×	130 0.3×	4 0.0×	15	575
Pauline Raaschou Sweden	10	182 0.1×	470 0.8×	155 0.3×	187 0.4×	3 0.0×	21	843
Aurora Navajas Spain	18	239 0.2×	62 0.1×	143 0.3×	33 0.1×	24 0.1×	41	1.1k

Countries citing papers authored by Robyn J. Levy

Since Specialization

Citations

This map shows the geographic impact of Robyn J. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn J. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn J. Levy more than expected).

Fields of papers citing papers by Robyn J. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn J. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn J. Levy. The network helps show where Robyn J. Levy may publish in the future.

Co-authorship network of co-authors of Robyn J. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn J. Levy. A scholar is included among the top collaborators of Robyn J. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn J. Levy. Robyn J. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wasserman, Richard L., William R. Lumry, James B. Harris, et al.. (2016). Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease. Journal of Clinical Immunology. 36(6). 590–599. 23 indexed citations

Li, H. Henry, Dumitru Moldovan, Jonathan A. Bernstein, et al.. (2015). Recombinant Human-C1 Inhibitor Is Effective and Safe for Repeat Hereditary Angioedema Attacks. The Journal of Allergy and Clinical Immunology In Practice. 3(3). 417–423. 30 indexed citations

Riedl, Marc A., Jonathan A. Bernstein, Henry Li, et al.. (2014). Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Annals of Allergy Asthma & Immunology. 112(2). 163–169.e1. 60 indexed citations

Riedl, Marc A., Robyn J. Levy, Daniel Suez, et al.. (2013). Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. Annals of Allergy Asthma & Immunology. 110(4). 295–299. 42 indexed citations

Relan, Anurag, André C. Knulst, Dumitru Moldovan, et al.. (2012). Clinical Impact of Peripheral Attacks in Hereditary Angioedema Patients. The American Journal of Medicine. 125(9). 937.e17–937.e24. 19 indexed citations

Bewtra, Againdra K., Robyn J. Levy, Richard L. Wasserman, et al.. (2012). Per-Attack Reporting of Prodromal Symptoms Concurrent with C1-Inhibitor Treatment of Hereditary Angioedema Attacks. Advances in Therapy. 29(10). 913–922. 24 indexed citations

Schranz, Jennifer, Robyn J. Levy, William R. Lumry, et al.. (2012). Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Subcutaneous (SC) Cinryze® (C1 inhibitor (C1 INH) with Recombinant Human Hyaluronidase (rHuPH20) in Subjects with Hereditary Angioedema (HAE). Journal of Allergy and Clinical Immunology. 129(2). AB369–AB369. 4 indexed citations

Lumry, William R., H. Henry Li, Robyn J. Levy, et al.. (2011). Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Annals of Allergy Asthma & Immunology. 107(6). 529–537.e2. 178 indexed citations

Sheffer, Albert L., Marilyn Campion, Robyn J. Levy, et al.. (2011). Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies. Journal of Allergy and Clinical Immunology. 128(1). 153–159.e4. 49 indexed citations

10.

Riedl, Marc A., David Hurewitz, Robyn J. Levy, et al.. (2011). Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Annals of Allergy Asthma & Immunology. 108(1). 49–53. 24 indexed citations

11.

Craig, Timothy, Againdra K. Bewtra, Sami L. Bahna, et al.. (2011). C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study. Allergy. 66(12). 1604–1611. 104 indexed citations

12.

Lumry, William R., Robyn J. Levy, Paul C. Potter, et al.. (2011). Results From FAST-3: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Subcutaneous Icatibant in Patients with Acute Hereditary Angioedema (HAE) Attacks. Journal of Allergy and Clinical Immunology. 127(2). AB1–AB1. 10 indexed citations

13.

Cicardi, Marco, Robyn J. Levy, Donald McNeil, et al.. (2010). Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema. New England Journal of Medicine. 363(6). 523–531. 234 indexed citations

14.

Levy, Robyn J., William R. Lumry, Donald McNeil, et al.. (2010). EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. Annals of Allergy Asthma & Immunology. 104(6). 523–529. 116 indexed citations

15.

Craig, Timothy, Richard L. Wasserman, Robyn J. Levy, et al.. (2010). Prospective Study of Rapid Relief Provided by C1 Esterase Inhibitor in Emergency Treatment of Acute Laryngeal Attacks in Hereditary Angioedema. Journal of Clinical Immunology. 30(6). 823–829. 37 indexed citations

16.

Wasserman, Richard L., Robyn J. Levy, Againdra K. Bewtra, et al.. (2010). Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks. Annals of Allergy Asthma & Immunology. 106(1). 62–68. 13 indexed citations

17.

Bernstein, Jonathan A., Bruce Ritchie, Robyn J. Levy, et al.. (2010). Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks. Annals of Allergy Asthma & Immunology. 105(2). 149–154. 24 indexed citations

18.

Zuraw, Bruce L., Marco Cicardi, Robyn J. Levy, et al.. (2010). Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. Journal of Allergy and Clinical Immunology. 126(4). 821–827.e14. 174 indexed citations

19.

Levy, Robyn J., et al.. (2005). Safety and Efficacy in Children with Persistent Asthma Treated with Formoterol 10 µg BID Delivered via Certihaler ^™ : A Novel Multidose Dry-Powder Inhaler. Pediatric Asthma Allergy & Immunology. 18(1). 25–35. 10 indexed citations

20.

Levy, Robyn J. & Ronald L Krall. (1984). Treatment of Status Epilepticus With Lorazepam. Archives of Neurology. 41(6). 605–611. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact